| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.7 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.8 |